Literature DB >> 9663620

Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water.

C B McCoy1, L R Metsch, D D Chitwood, P Shapshak, S T Comerford.   

Abstract

OBJECTIVES: To describe and estimate the frequency of different types of drug preparation and injection practices that could result in the transfer of blood and blood-borne infections among injection drug users (IDUs).
METHODS: We analyzed data from interviews administered to 12,323 active IDUs recruited from 19 sites in the United States. The interviews ascertained drug-related behaviors during the previous 30 days.
RESULTS: 31.9% of IDUs reported that they engaged in the use of both needle/syringes and cookers/cotton/water previously used by another IDU; 8.6% engaged only in the use of needle/syringes previously used by another IDU; 17.5% engaged only in the use of cookers/cotton/water previously used by another IDU; and 42.0% reported using neither needle/syringes nor cookers/cotton/water previously used by another IDU. Only 12.6% reported use of new (never-used) needle/syringes. The 3935 IDUs who used both needle/syringes and cookers/cotton/water that had been previously used by another IDU had more than 311.000 potential exposures to blood-borne infections from these high-risk practices in 30 days; about 64% of these exposures were from multiperson use of cookers/cotton/water.
CONCLUSIONS: Programs to limit parenteral transmission of HIV and other blood-borne infections among IDUs must consider all drug preparation and injection practices that could allow transfer of blood and blood-borne infections among IDUs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9663620     DOI: 10.1097/00042560-199802001-00006

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  17 in total

1.  Changes in injection risk behavior associated with participation in the Seattle needle-exchange program.

Authors:  H Hagan; H Thiede
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

Review 2.  Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop.

Authors:  Scott Burris; Kim M Blankenship; Martin Donoghoe; Susan Sherman; Jon S Vernick; Patricia Case; Zita Lazzarini; Stephen Koester
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

3.  Novel heroin injection practices: implications for transmission of HIV and other bloodborne pathogens.

Authors:  Michael C Clatts; Le M Giang; Lloyd A Goldsamt; Huso Yi
Journal:  Am J Prev Med       Date:  2007-06       Impact factor: 5.043

4.  Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection.

Authors:  Jessica M Breslow; M Alexandra Monroy; John M Daly; Joseph J Meissler; John Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-09       Impact factor: 4.147

Review 5.  Prevention and treatment of hepatitis C in injection drug users.

Authors:  Brian R Edlin
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

6.  Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users.

Authors:  H Thiede; M Romero; K Bordelon; H Hagan; C S Murrill
Journal:  J Urban Health       Date:  2001-06       Impact factor: 3.671

7.  Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.

Authors:  Stephanie R Bialek; William A Bower; Karen Mottram; Dave Purchase; T Nakano; Omana Nainan; Ian T Williams; Beth P Bell
Journal:  J Urban Health       Date:  2005-07-27       Impact factor: 3.671

Review 8.  Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

Authors:  Brian R Edlin; Thomas F Kresina; Daniel B Raymond; Michael R Carden; Marc N Gourevitch; Josiah D Rich; Laura W Cheever; Victoria A Cargill
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

9.  Predictors of sharing injection equipment by HIV-seropositive injection drug users.

Authors:  Carl A Latkin; Amy S Buchanan; Lisa R Metsch; Kelly Knight; Mary H Latka; Yuko Mizuno; Amy R Knowlton
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

10.  A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.

Authors:  Marie Jauffret-Roustide; Yann Le Strat; Elisabeth Couturier; Damien Thierry; Marc Rondy; Martine Quaglia; Nicolas Razafandratsima; Julien Emmanuelli; Gaelle Guibert; Francis Barin; Jean-Claude Desenclos
Journal:  BMC Infect Dis       Date:  2009-07-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.